Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_282d8844066f5f683bc2463742373508 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c92d4a62df5f94768694363768d0a0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_638336aa54551464013be94ef40d5fb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_584666f2b0a05e89725ca5794c85e904 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa03b54c1e2494223917c9bd9e5edde8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
filingDate |
2010-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3da722ccc95482886bd7cbfd98e9a268 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bfe0b48b6896bc08679802653b03b18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_597812f944de7f13b4aff023b3e9aadf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b65c93a69b9889a9af6406cf10c106da |
publicationDate |
2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011033005-A3 |
titleOfInvention |
Cells for transient expression and uses thereof |
abstract |
This invention relates to the transient expression of heterologous polypeptides in mammalian cell lines. Specifically it relates to an expression-enhanced cell line derived from a parent cell line, the expression-enhanced cell line comprising nucleic acid encoding Epstein-Barr Virus Nuclear Antigen 1 or a functional derivative, analogue, or variant thereof; and further comprising: (a) a nucleic acid encoding an exogenous glutamine synthetase; (b) a nucleic acid encoding an endogenous glutamine synthetase, wherein the endogenous glutamine is arranged to have enhanced enzymatic activity and/or enhanced expression relative to the parent cell line under comparable conditions; or (c) both (a) and (b). |
priorityDate |
2009-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |